What's new in dermatologic therapy? - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:
Infection Control Center
DVM Bayer Sponsored by:


What's new in dermatologic therapy?
Five new drugs show promise in treating dermatomyositis, atopic dermatitis, papillomavirus infection, and more. Find out if they should be in your treatment arsenal.


14. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002;46(2):228-241.

15. Misseghers BS, Binnington AG, Mathews KA. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs. Can Vet J 2000;41(8):623-627.

16. Marsella R, Nicklin CF, Saglio S, et al. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Vet Dermatol 2004;15(5):294-303.

17. Bensignor E, Olivry T. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. Vet Dermatol 2005;16(1):52-60.

18. Griffies JD, Mendelsohn CL, Rosenkrantz WS. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs. J Am Anim Hosp Assoc 2004;40(1):29-41.

19. Meingassner JG, Fahrngruber H, Bavandi A. Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A. J Invest Dermatol 2003;121(1):77-80.

20. Cummins JM, Krakowka GS, Thompson CG. Systemic effects of interferons after oral administration in animals and humans. Am J Vet Res 2005;66(1):164-176.

21. Stokking LB, Ehrhart EJ, Lichtensteiger CA, et al. Pigmented epidermal plaques in three dogs. J Am Anim Hosp Assoc 2004;40(5):411-417.

22. Thompson LA, Grieshaber TL, Glickman L, et al. Human recombinant interferonalpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study. Vet Ther 2004;5(1):75-81.

23. Martin V, Najbar W, Gueguen S, et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 2002;89(2-3):115-127.

24. de Mari K, Maynard L, Eun HM, et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet Rec 2003;152(4):105-108.

25. de Mari K, Maynard L, Sanquer A, et al. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern Med 2004;18(4):477-482.

26. Southerden P, Gorrel C. Treatment of a case of refractory feline chronic gingivostomatitis with feline recombinant interferon omega. J Small Anim Pract 2007;48(2):104-106.

27. Carlotti D, Madiot G, et al. Use of recombinant omega interferon therapy in canine atopic dermatitis: a pilot study. Vet Dermatol 2004;15(s):32.

28. Gutzwiller ME, Brachelente C, Taglinger K, et al. Feline herpes dermatitis treated with interferon omega. Vet Dermatol 2007;18(1):50-54.

29. Iwasaki T, Hasegawa A. A randomized comparative clinical trial of recombinant canine interferon-gamma (KT-100) in atopic dogs using antihistamine as control. Vet Dermatol 2006;17(3):195-200.


Click here